Physician profile
Nora Anne Hadlock
NPI 1346989811
$385.41
in general payments reported to CMS, 2019-2025
16 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.65 · 2023: $108 · 2024: $77.07 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $54.10 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $33.42 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $32.69 | 2022-2024 | |
| Astellas Pharma US INC | $31.84 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $27.95 | 2025 | |
| Coopersurgical, INC. | $26.14 | 2024 | Paragard T 380a |
| Regeneron Healthcare Solutions, INC. | $25.47 | 2023 | Dupixent |
| Sumitomo Pharma America, INC. | $19.57 | 2025 | Myfembree |
| Lilly USA, LLC | $19.28 | 2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $18.71 | 2023 | Trelegy Ellipta |
| Pacira Pharmaceuticals Incorporated | $18.61 | 2025 | Exparel |
| Shield Therapeutics INC | $16.66 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $15.91 | 2023 | Farxiga |
| Organon LLC | $15.57 | 2025 | Nexplanon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.88 | 2023 | Trulance, Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Hadlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.